Vitamin D Receptor Upregulation and Ferroptosis in Salivary Gland Dysfunction: Insights from Sod1 Knockout Mice

Study Background and Research Question

Salivary gland hypofunction, manifesting as xerostomia (dry mouth), is a prevalent clinical problem with significant impacts on oral health and quality of life. It disproportionally affects women, especially with advancing age and in the context of autoimmune disease or cancer therapies. While oxidative stress is recognized as a major contributor to salivary gland dysfunction, the precise molecular mechanisms that connect systemic redox imbalance, sex differences, and glandular cell death remain incompletely understood. The recent study by Han et al. (Free Radic Biol Med, 2025) addressed this knowledge gap by investigating the role of the vitamin D receptor (VDR) and ferroptosis in mediating salivary hyposecretion under conditions of elevated oxidative stress.

Key Innovation from the Reference Study

The central innovation of this work lies in demonstrating that VDR upregulation acts as a molecular driver of ferroptosis—a regulated, iron-dependent cell death process characterized by lipid peroxidation—in salivary glands, leading to reduced saliva production. Importantly, this VDR-ferroptosis axis was shown to be sex-specific, with significant effects observed only in female Sod1 knockout (SKO) mice. This mechanistic insight connects hormonal regulation, redox biology, and cell death pathways in the pathogenesis of salivary gland dysfunction.

Methods and Experimental Design Insights

• Animal Model: The study utilized Sod1 knockout (SKO) mice to model endogenous oxidative stress, given Sod1’s role as a key cytosolic superoxide scavenger. Both male and female mice were evaluated to uncover sex-dependent effects.
• Phenotypic Assessment: Salivary secretion rates were measured following pilocarpine stimulation to quantify gland function.
• Molecular Profiling: Salivary glands were subjected to transcriptomic analysis, with validation of ferroptosis, VDR, and inflammation-related gene expression via qPCR and immunohistochemistry.
• Cell Culture Work: Human A253 salivary epithelial cells were exposed to 4-nitroquinoline N-oxide (4NQO) to induce oxidative stress, and VDR was overexpressed to dissect downstream molecular effects.
• Mechanistic Assays: Chromatin immunoprecipitation and promoter analyses identified VDR’s direct transcriptional regulation of the transferrin receptor (TFRC), a key mediator of iron uptake and ferroptosis susceptibility.

Core Findings and Why They Matter

Han et al. (2025) reported several interlocking discoveries:

• Elevated ROS and VDR in Female SKO Mice: Only female SKO mice exhibited both increased endogenous ROS and upregulated VDR expression in salivary glands, correlating with a marked reduction in saliva flow.
• Ferroptosis Activation: Transcriptomic and histological analyses showed increased expression of ferroptosis-associated genes (e.g., TFRC, ACSL4) and markers of lipid peroxidation, consistent with ferroptotic activity.
• VDR Drives TFRC Expression and Ferroptosis: Overexpression of VDR in A253 cells increased TFRC promoter activity and mRNA levels, sensitizing cells to iron-dependent lipid peroxidation and death, thereby linking hormonal signaling to ferroptosis pathways.
• Sex-Specificity: These effects were not observed in male SKO mice, highlighting the importance of sex hormones and receptor cross-talk in ferroptosis susceptibility within glandular tissue.

These findings establish a new mechanistic paradigm where VDR upregulation enhances ferroptosis via TFRC, under conditions of oxidative stress, to drive salivary gland hypofunction. This has broad implications for understanding why postmenopausal women are particularly vulnerable to xerostomia and related disorders.

Comparison with Existing Internal Articles

Several recent internal reviews have focused on the role of ferroptosis and its modulation in epithelial and organ-specific contexts:

• Liproxstatin-1: Mechanistic Mastery and Strategic Horizon provides detailed insights into how potent ferroptosis inhibitors, such as Liproxstatin-1, enable translational research targeting lipid peroxidation and cell death in epithelial dysfunction. The current reference study complements this by identifying the upstream regulatory role of VDR in initiating these ferroptotic events in salivary glands.
• Liproxstatin-1: Applied Ferroptosis Inhibitor Protocols & Insights discusses experimental workflows for inhibiting ferroptosis in GPX4-deficient models. This aligns with the mechanistic evidence from Han et al., where GPX4-linked defense pathways are implicated in the observed cell death phenotype.
• Liproxstatin-1: A Potent Ferroptosis Inhibitor for Precise Pathway Dissection highlights the use of Liproxstatin-1 in renal and hepatic injury models, supporting the transferability of ferroptosis-targeted strategies across organ systems, including salivary glands.

In summary, while internal articles have focused on the practical deployment of ferroptosis inhibitors and protocol optimization, the reference paper uniquely advances our understanding of endogenous regulation (i.e., via VDR) and sex differences in ferroptosis-mediated tissue dysfunction.

Limitations and Transferability

Despite its strengths, several limitations merit consideration:

• Species and Sex Specificity: The findings rely on murine models and female-specific phenotypes. While the mechanisms are plausible in humans, direct clinical extrapolation requires further validation in human tissue and diverse patient populations.
• Oxidative Stress Model: The Sod1 knockout mouse is a robust model for endogenous oxidative stress, but may not fully recapitulate all forms of glandular injury seen in human disease (e.g., irradiation, autoimmunity).
• Therapeutic Inhibition of Ferroptosis: While VDR upregulation is shown to promote ferroptosis, the study did not directly test the protective efficacy of ferroptosis inhibitors (such as Liproxstatin-1) in this context. However, related studies in organ injury and GPX4-deficient models provide a rationale for this approach.

Protocol Parameters

• Oxidative stress induction (in vitro): 4NQO exposure in A253 salivary epithelial cells to mimic elevated ROS conditions.
• VDR overexpression: Transient transfection or viral delivery in cell models to probe downstream ferroptosis gene regulation.
• Ferroptosis detection: Quantification of lipid peroxidation (e.g., BODIPY 581/591 C11 oxidation), TFRC expression, and histological detection of cell death markers.
• Animal model: Female Sod1 knockout mice aged to ensure phenotypic manifestation of oxidative stress-induced gland dysfunction.
• Potential workflow suggestion: For prospective intervention studies, include a ferroptosis inhibitor (e.g., Liproxstatin-1 at 10 mg/kg i.p., as reported in product documentation) to test rescue of salivary hyposecretion and tissue preservation.

Research Support Resources

Researchers aiming to dissect ferroptosis pathways in salivary gland dysfunction and related oxidative stress models can incorporate potent ferroptosis inhibitors into their experimental workflows. Liproxstatin-1 (SKU B4987) is a well-characterized small molecule that blocks ferroptotic cell death and has established efficacy in suppressing lipid peroxidation, particularly in GPX4-deficient or injury models, as detailed in the product information. APExBIO provides protocol-ready Liproxstatin-1 for use in both in vitro and in vivo research, supporting high-fidelity ferroptosis research workflows.